Log in

ETR:CE2CropEnergies Stock Price, Forecast & News

+0.43 (+5.85 %)
(As of 05/25/2020 01:39 PM ET)
Today's Range
Now: €7.78
50-Day Range
MA: €7.91
52-Week Range
Now: €7.78
Volume66,288 shs
Average VolumeN/A
Market Capitalization$678.81 million
P/E Ratio11.56
Dividend Yield4.17%
CropEnergies AG manufactures and distributes bioethanol and other biofuels, and related products produced from grain and other agricultural raw materials in Germany and internationally. The company produces and sells protein food and animal feed products, including ProtiGrain, a protein animal feed for various types of livestock and pets; wheat gluten for food and animal feed; and ProtiWanze, a liquid protein for cattle and pigs. It also offers liquefied carbonic acid; and produces neutral alcohol for beverage, food, cosmetics, and pharmaceutical industries, as well as for industrial applications. The company was founded in 2006 and is headquartered in Mannheim, Germany. CropEnergies AG is a subsidiary of Südzucker AG.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.5Dividend Strength: 2.5Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.13 out of 5 stars

Industry, Sector and Symbol

Industry Oil & Gas Integrated
Phone49 621 71 41 9000



Sales & Book Value

Annual Sales$850.10 million
Cash Flow€0.35 per share
Book Value€5.51 per share



Market Cap$678.81 million
Next Earnings DateN/A
OptionableNot Optionable

Receive CE2 News and Ratings via Email

Sign-up to receive the latest news and ratings for CE2 and its competitors with MarketBeat's FREE daily newsletter.

CropEnergies (ETR:CE2) Frequently Asked Questions

How has CropEnergies' stock been impacted by COVID-19 (Coronavirus)?

CropEnergies' stock was trading at €8.17 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, CE2 stock has decreased by 4.8% and is now trading at €7.78. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of CropEnergies?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CropEnergies in the last year. There are currently 1 hold rating for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for CropEnergies.

Has CropEnergies been receiving favorable news coverage?

Headlines about CE2 stock have been trending somewhat positive recently, according to InfoTrie. The research group identifies positive and negative media coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. CropEnergies earned a daily sentiment score of 1.5 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the company's share price in the near term. View the latest news aboutCropEnergies.

Who are some of CropEnergies' key competitors?

What other stocks do shareholders of CropEnergies own?

Who are CropEnergies' key executives?

CropEnergies' management team includes the following people:
  • Mr. Joachim Lutz, CEO & Member of Exec. Board (Age 63)
  • Stephan Meeder, CFO & Member of Exec. Board (Age 49)
  • Mr. Michael Friedmann, Chief Sales Officer & Member of Exec. Board (Age 64)

What is CropEnergies' stock symbol?

CropEnergies trades on the ETR under the ticker symbol "CE2."

What is CropEnergies' stock price today?

One share of CE2 stock can currently be purchased for approximately €7.78.

How big of a company is CropEnergies?

CropEnergies has a market capitalization of $678.81 million and generates $850.10 million in revenue each year.

What is CropEnergies' official website?

The official website for CropEnergies is www.cropenergies.com.

How can I contact CropEnergies?

The company can be reached via phone at 49 621 71 41 9000.

This page was last updated on 5/25/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.